Hemodialysis-associated cardiomyopathy: a newly defined disease entity.

摘要: Cardiovascular disease is the most common cause of greatly elevated rates mortality characteristic patients undergoing maintenance hemodialysis. This article an attempt to describe complex and evolving features cardiac routinely encountered in HD patients. Furthermore, by trying appreciate pathophysiological drivers, crucial interaction with treatment itself, this seeks define setting (HD-associated cardiomyopathy) as a unique entity. By understanding phenotype basis HD-associated cardiomyopathy, we can develop evolved dominant processes involved its development offer up dialysis-based interventions specifically designed mitigate cumulative ischemic insults consequent conventional treatment. explores justification approach recent evidence efficacy.